Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Um, Yumi | - |
dc.contributor.author | Cho, Sungsik | - |
dc.contributor.author | Woo, Ho Bum | - |
dc.contributor.author | Kim, Yong Kee | - |
dc.contributor.author | Kim, Hanna | - |
dc.contributor.author | Ham, Jungyeob | - |
dc.contributor.author | Kim, Su-Nam | - |
dc.contributor.author | Ahn, Chan Mug | - |
dc.contributor.author | Lee, Seokjoon | - |
dc.date.accessioned | 2024-01-20T23:31:47Z | - |
dc.date.available | 2024-01-20T23:31:47Z | - |
dc.date.created | 2021-09-03 | - |
dc.date.issued | 2008-04-01 | - |
dc.identifier.issn | 0968-0896 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/133564 | - |
dc.description.abstract | In order to discover novel multidrug resistance (MDR) reversal agents for efficient cancer chemotherapy, the unsymmetrical curcumin mimics with various amide moieties (6-19) were synthesized and evaluated their MDR reversal activities in MDR cell line KBV20C. Among the tested compounds, 13, 16, and 17 showed potent MDR reversal activities by inhibiting drug efflux function of P-glycoprotein in KB20C cells, and almost recovered the cytotoxicity of vincristine and paclitaxel against KBV20C cell to the degree of potency against drug sensitive KB cells. (C) 2008 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | P-GLYCOPROTEIN | - |
dc.subject | BIOLOGICAL EVALUATION | - |
dc.subject | CANCER-CELLS | - |
dc.subject | DERIVATIVES | - |
dc.subject | ANTICANCER | - |
dc.subject | MODULATION | - |
dc.subject | INHIBITION | - |
dc.subject | THERAPY | - |
dc.subject | ANALOGS | - |
dc.subject | AGENTS | - |
dc.title | Synthesis of curcumin mimics with multidrug resistance reversal activities | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.bmc.2008.02.012 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY, v.16, no.7, pp.3608 - 3615 | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY | - |
dc.citation.volume | 16 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 3608 | - |
dc.citation.endPage | 3615 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000255245900014 | - |
dc.identifier.scopusid | 2-s2.0-41649097357 | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | P-GLYCOPROTEIN | - |
dc.subject.keywordPlus | BIOLOGICAL EVALUATION | - |
dc.subject.keywordPlus | CANCER-CELLS | - |
dc.subject.keywordPlus | DERIVATIVES | - |
dc.subject.keywordPlus | ANTICANCER | - |
dc.subject.keywordPlus | MODULATION | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | ANALOGS | - |
dc.subject.keywordPlus | AGENTS | - |
dc.subject.keywordAuthor | curcumin | - |
dc.subject.keywordAuthor | curcumin mimics | - |
dc.subject.keywordAuthor | multidrug resistance | - |
dc.subject.keywordAuthor | multidrug resistance reversal activities | - |
dc.subject.keywordAuthor | anticancer | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.